Enzolytics, Inc. (OTCMKTS:ENZC) Short Interest Update

Enzolytics, Inc. (OTCMKTS:ENZC) saw a large growth in short interest in January. As of January 15th, there was short interest totalling 57,300 shares, a growth of 28,550.0% from the December 31st total of 200 shares. Based on an average daily trading volume, of 21,887,900 shares, the days-to-cover ratio is presently 0.0 days.

Enzolytics Stock Performance

Shares of OTCMKTS:ENZC traded down $0.00 during midday trading on Tuesday, hitting $0.00. The stock had a trading volume of 10,299,364 shares, compared to its average volume of 5,525,667. Enzolytics has a fifty-two week low of $0.00 and a fifty-two week high of $0.02.

Enzolytics Company Profile

Enzolytics Inc, a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy.